Lv41
430 积分 2021-12-23 加入
Emerging Therapy Critique: Glibenclamide for Cerebral Edema—A Semi-CHARMed Treatment
20天前
已完结
Malignant Cerebral Edema after Large-Core Anterior Circulation Stroke in the Thrombectomy Era: Prediction and Neurocritical Care Pathways
22天前
已完结
Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials
1个月前
已完结
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial
3个月前
已完结
Intravenous Glyburide in Medical and Endovascular‐Treated Large‐Core Stroke: A Subgroup Analysis of the CHARM Randomized Clinical Trial
3个月前
已完结
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial
3个月前
已完结
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes
8个月前
已完结
Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study
11个月前
已完结
Efficacy and safety of sacubitril/allisartan for the treatment of primary hypertension: a phase 2 randomized, double-blind study
11个月前
已完结
SGLT2 Inhibitors and Mechanisms of Hypertension
1年前
已完结
皖公网安备34019202002308
